Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

68 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Treatment of melanoma cells with a bcl-2/bcl-xL antisense oligonucleotide induces antiangiogenic activity.
Del Bufalo D, Trisciuoglio D, Scarsella M, Zangemeister-Wittke U, Zupi G. Del Bufalo D, et al. Among authors: trisciuoglio d. Oncogene. 2003 Nov 20;22(52):8441-7. doi: 10.1038/sj.onc.1206999. Oncogene. 2003. PMID: 14627985
Bcl-2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity.
Del Bufalo D, Trisciuoglio D, Biroccio A, Marcocci L, Buglioni S, Candiloro A, Scarsella M, Leonetti C, Zupi G. Del Bufalo D, et al. Among authors: trisciuoglio d. J Cell Biochem. 2001 Aug 21-Sep 5;83(3):473-83. doi: 10.1002/jcb.1245. J Cell Biochem. 2001. PMID: 11596115
relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells.
Ricca A, Biroccio A, Trisciuoglio D, Cippitelli M, Zupi G, Del Bufalo D. Ricca A, et al. Among authors: trisciuoglio d. Br J Cancer. 2001 Dec 14;85(12):1914-21. doi: 10.1054/bjoc.2001.2174. Br J Cancer. 2001. PMID: 11747334 Free PMC article.
Endothelin-1 protects ovarian carcinoma cells against paclitaxel-induced apoptosis: requirement for Akt activation.
Del Bufalo D, Di Castro V, Biroccio A, Varmi M, Salani D, Rosanò L, Trisciuoglio D, Spinella F, Bagnato A. Del Bufalo D, et al. Among authors: trisciuoglio d. Mol Pharmacol. 2002 Mar;61(3):524-32. doi: 10.1124/mol.61.3.524. Mol Pharmacol. 2002. PMID: 11854432
Bcl-2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity.
Iervolino A, Trisciuoglio D, Ribatti D, Candiloro A, Biroccio A, Zupi G, Del Bufalo D. Iervolino A, et al. Among authors: trisciuoglio d. FASEB J. 2002 Sep;16(11):1453-5. doi: 10.1096/fj.02-0122fje. Epub 2002 Jul 1. FASEB J. 2002. PMID: 12205045
Bcl-2 has differing effects on the sensitivity of breast cancer cells depending on the antineoplastic drug used.
Del Bufalo D, Biroccio A, Trisciuoglio D, Bruno T, Floridi A, Aquino A, Zupi G. Del Bufalo D, et al. Among authors: trisciuoglio d. Eur J Cancer. 2002 Dec;38(18):2455-62. doi: 10.1016/s0959-8049(02)00391-x. Eur J Cancer. 2002. PMID: 12460791
The sensitivity to four multidrug resistance (MDR)-related drugs (doxorubicin (ADR), vincristine (VCR), vinblastine (VBL), actinomycin D (ACTD)) and three MDR-non-related drugs (cisplatin (DDP), bischloroethylnitrosourea (BCNU), 5-fluorouracil (5-FU)) was evaluated by the …
The sensitivity to four multidrug resistance (MDR)-related drugs (doxorubicin (ADR), vincristine (VCR), vinblastine (VBL), actinomycin D
bcl-2 induction of urokinase plasminogen activator receptor expression in human cancer cells through Sp1 activation: involvement of ERK1/ERK2 activity.
Trisciuoglio D, Iervolino A, Candiloro A, Fibbi G, Fanciulli M, Zangemeister-Wittke U, Zupi G, Del Bufalo D. Trisciuoglio D, et al. J Biol Chem. 2004 Feb 20;279(8):6737-45. doi: 10.1074/jbc.M308938200. Epub 2003 Dec 1. J Biol Chem. 2004. PMID: 14660675
Lonidamine causes inhibition of angiogenesis-related endothelial cell functions.
Del Bufalo D, Trisciuoglio D, Scarsella M, D'Amati G, Candiloro A, Iervolino A, Leonetti C, Zupi G. Del Bufalo D, et al. Among authors: trisciuoglio d, d amati g. Neoplasia. 2004 Sep-Oct;6(5):513-22. doi: 10.1593/neo.04133. Neoplasia. 2004. PMID: 15548359 Free PMC article.
Trastuzumab down-regulates Bcl-2 expression and potentiates apoptosis induction by Bcl-2/Bcl-XL bispecific antisense oligonucleotides in HER-2 gene--amplified breast cancer cells.
Milella M, Trisciuoglio D, Bruno T, Ciuffreda L, Mottolese M, Cianciulli A, Cognetti F, Zangemeister-Wittke U, Del Bufalo D, Zupi G. Milella M, et al. Among authors: trisciuoglio d. Clin Cancer Res. 2004 Nov 15;10(22):7747-56. doi: 10.1158/1078-0432.CCR-04-0908. Clin Cancer Res. 2004. PMID: 15570009
Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function.
Del Bufalo D, Rizzo A, Trisciuoglio D, Cardinali G, Torrisi MR, Zangemeister-Wittke U, Zupi G, Biroccio A. Del Bufalo D, et al. Among authors: trisciuoglio d. Cell Death Differ. 2005 Nov;12(11):1429-38. doi: 10.1038/sj.cdd.4401670. Cell Death Differ. 2005. PMID: 15920535
68 results
Jump to page
Feedback